I am a
Home I AM A Search Login

Papers of the Week


J Pain Res


Transcutaneous Electrical Acupoint Stimulation for Moderate to Severe Pain in Hepatocellular Carcinoma: A Protocol for a Randomized Controlled Trial.


Wu P, Zhu L, Zheng S-Y, Li J-X, Wu M-D, Wang W-J, Hou Y-C, Li J, Wu H-G
J Pain Res. 2022; 15:1889-1896.
PMID: 35832212.


Cancer-related pain is one of the primary symptoms of patients with hepatocellular carcinoma (HCC). Previous studies have shown that transcutaneous electrical acupoint stimulation (TEAS) is effective in treating patients with acute or chronic pain. In China, it is indispensable to evaluate the efficacy of TEAS in combination with opioids for the treatment of moderate to severe HCC-related pain.